Literature DB >> 9741468

Survival of children with Down syndrome in South America. ECLAMC-Downsurv Group. Latin American Collaborative Study of Congenital Malformations.

E E Castilla1, M Rittler, M G Dutra, J S Lopez-Camelo, H Campaña, J E Paz, I M Orioli.   

Abstract

The first step of all healthcare actions aimed at promoting an appropriate quality of life for infants affected by Down syndrome (DS) is to ensure their survival. This investigation was aimed at estimating the infant mortality rate of infants affected with DS in urban populations of South America. Thirty-three hospitals included in the Latin American Collaborative Study of Congenital Malformations (ECLAMC) distributed in 23 cities of 5 South American countries followed 360 liveborn DS cases born during the 1988-1992 period. Families were recontacted after the infant should have reached the age of one year. The collected data included information about health status; i.e., frequency and dates of diagnosed illnesses and hospital admissions, and, in case of death, information on date, place and cause of death, and illness immediately before death. Information about the interviews included place, date, and name of the interviewer. A closed questionnaire was employed by the interviewers, mostly physicians, nurses, and social workers. Life table analysis up to the age of one year was performed by the actuarial survival method. The overall mean survival at age one year was 0.736 (SE=0.023). Thirty-three (9.2%) of the 360 cases died neonatally, and 62 (17.2%) within the remaining 2-to-12-month interval. The probability of survival at one year of age did not differ between public (209 cases; mean 0.718; SE=0.031) and private (151 cases; mean: 0.762; SE=0.035) (chi2:0.87; df:1; P >0.05) health systems. The 150 DS cases with a congenital heart defect (CHD) had a significantly lower P robability of survival at the age of one year (mean: 0.660; SE: 0.039) than did the 210 cases without CHD (mean: 0.790; SE: 0.028) (chi2:6.67; df:1; P <0.01). The death rate in the first year of life for DS cases without a detected cardiac defect (21%) is significantly higher than that reported in developed countries; namely, 16% from Italy, 11% from Canada, 10% from England, and 7% from Denmark.

Entities:  

Mesh:

Year:  1998        PMID: 9741468     DOI: 10.1002/(sici)1096-8628(19980901)79:2<108::aid-ajmg6>3.0.co;2-m

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Survival of children born with congenital anomalies.

Authors:  S Dastgiri; W H Gilmour; D H Stone
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

2.  A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.

Authors:  Daniel Satgé; Charles A Stiller; Stefan Rutkowski; André O von Bueren; Brigitte Lacour; Danièle Sommelet; Motoi Nishi; Maura Massimino; Maria Luisa Garré; Florencia Moreno; Henrik Hasle; Zsuzsanna Jakab; Mark Greenberg; Nicolas von der Weid; Claudia Kuehni; Oscar Zurriaga; Maria-Luisa Vicente; Rafael Peris-Bonet; Martin Benesch; Michel Vekemans; Sheena G Sullivan; Christian Rickert
Journal:  J Neurooncol       Date:  2013-01-11       Impact factor: 4.130

3.  The effect of systematic pediatric care on neonatal mortality and hospitalizations of infants born with oral clefts.

Authors:  George L Wehby; Eduardo E Castilla; Norman Goco; Monica Rittler; Viviana Cosentino; Lorette Javois; Mark Kindem; Hrishikesh Chakraborty; Graca Dutra; Jorge S López-Camelo; Iêda M Orioli; Jeffrey C Murray
Journal:  BMC Pediatr       Date:  2011-12-28       Impact factor: 2.125

4.  Prevalence of congenital heart defects associated with Down syndrome in Korea.

Authors:  Min-A Kim; You Sun Lee; Nan Hee Yee; Jeong Soo Choi; Jung Yun Choi; Kyung Seo
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.